Target intelligence / Profile preview

Ultraviolet photon

Molecular classification
Other
01

Overview

Ultraviolet photons are quantum packets of electromagnetic radiation with wavelengths between 100 and 400 nanometers (encompassing UVA, UVB, and UVC bands). In biology, they are best known for their ability to cause DNA damage (e.g., formation of pyrimidine dimers) and other cellular disturbances through both direct absorption by key molecules (DNA, proteins) and indirect effects (generation of reactive oxygen species). While excessive UV exposure is associated with increased risk of skin cancer, photoaging, immunosuppression, and ocular damage, some controlled UVB exposure is critical for endogenous vitamin D synthesis. Ultraviolet photons are not considered drug targets in the classical sense, but are important environmental factors and mediators of biological responses[3][4][5][6].

Other names
UV photonUltraviolet radiationUV lightUVR
02

Mechanism of action

Not applicable (UV photons cause effects through physical energy transfer and photochemistry, not conventional drug-target mechanisms; phototherapy leverages these properties for controlled effects)

03

Biological functions

DNA damage (formation of cyclobutane pyrimidine dimers and 6-4 photoproducts)Cell signaling disruptionApoptosis (programmed cell death)ImmunosuppressionVitamin D synthesis (UVB only)Melanogenesis (skin pigmentation)InflammationCellular stress response (e.g., autophagy, oxidative stress response)
04

Disease associations

Cancer (especially skin cancers: melanoma, basal cell carcinoma, squamous cell carcinoma)InflammationAutoimmune disease modulationPremature skin aging (photoaging)Eye diseases (e.g., cataract)Vitamin D deficiency (insufficient exposure)
05

Safety considerations

DNA mutation and carcinogenesisAcute skin effects (erythema/sunburn)Long-term photoagingImmunosuppressionEye damage (e.g., photokeratitis, cataract)Chronic inflammation
06

Biomarkers

DNA photoproducts (e.g., cyclobutane pyrimidine dimers)vitamin D statusp53 mutation status in skininflammatory cytokines (IL-1α, IL-6, TNF-α)markers of oxidative stress

Beyond the preview

Go deeper on Ultraviolet photon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultraviolet photon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call